SureTrader SureTrader SureTrader
Home > Boards > US OTC > Medical - Healthcare >

Paradigm Medical Industries Inc. (PDMI)

Add PDMI Price Alert      Hide Sticky   Hide Intro
Moderator: Risk vs Reward
Search This Board:
Last Post: 1/19/2017 11:45:48 AM - Followers: 302 - Board type: Free - Posts Today: 0

Paradigm Medical Industries, Inc.


Contact Info
  • 4273 South 590 West
  • Salt Lake City, UT 84123
Press Releases

Paradigm Medical Industries (PDMI)

Originally the creation of a merger between French Bar Industries and Paradigm Medical Inc. in early 1993, the company quickly became skilled in the development, manufacturing, sales, and marketing of medical devices utilizing innovative and dependable diagnostic technologies for the early detection of glaucoma and other eye disorders. 

Paradigm Medical Industries, Inc. has an exceptional history of acquiring superior medical devices and companies. In 1997 Paradigm acquired OBF Labs and the Ocular Blood Flow Analyzer (BFA). Today the BFA is the only medical device available that measures both IOP and Ocular Blood Flow, two key factors in the assessment and early treatment of glaucoma, circulatory abnormalities, and other eye maladies. In 1998 the company acquired proprietary UBM technology from Humphrey Systems. After extensive research and development Paradigm enhanced this technology to be more precise, user friendly, and detailed with its introduction of the P60 UBM, the first Windows based UBM, in early 2005. In 2000 Paradigm acquired Dicon, a manufacturer of advanced diagnostic instrumentation, and expanded its product line to include perimetry, topography, and pachymetry. Only Paradigm’s sophisticated perimeters perform testing strategies with voice recognition software, now available in 26 languages. Paradigm remains dedicated to developing or acquiring new technologies and devices that preserve the vision of tomorrow, today. 

Paradigm’s expertise lies with medical devices using UBM, A-scan, B-scan, pachymetry, perimetry, ocular electrophysiology, topography, tomography, and tonometry technologies. With over 17 years of experience Paradigm specializes in providing reliable, easy-to use equipment that provide the experienced practitioner unequalled value and performance, while remaining affordable for physicians starting new practices or opening up additional satellite offices. 

Paradigm Medical Industries, Inc. is a publicly owned company traded on the OTC/PK under the symbol

Two Consultants for PDMI
Steven Bayern & Thomas F. Motter 

Steven Bayern BIO 
Listed as Consultant in PR 


Mr. Bayern has over 30 years of experience in investment banking, venture capital, and trading 
and brokerage management, including having founded and served as a principal in three separate brokerage firms on Wall Street. He was founder and principal of Racz & Company, a NYSE member firm, founder and Chairman of S.J. Bayern & Company, an NASD member firm, and founder and Chairman of Win Capital Corporation, also an NASD member firm. Mr. Bayern was also involved in successfully raising capital for Paradigm Medical in 2001 and 2003, and in arranging for the merger between the Company and Vismed, Inc., dba Dicon in 2000. 

Holding an MBA from the Baruch School of Business CCNY earned in 1974, in Finance and Investments, Mr. Bayern has built his career in the financial industry based upon his ability to locate, structure and fund small cap and mid-market deals. To that end, he has consummated myriad transactions throughout his career while compiling a long and distinguished track record of success. 

In his capacity as a principal in broker/dealer ventures, Mr. Bayern has assisted a great many small and mid-size companies achieve public listing and trading status and is intimately familiar with the public equity markets on both the buy and sell sides. 

Having worked with numerous companies throughout the course of his career and having raised many hundreds of millions of dollars in equity capital for them, Mr. Bayern brings an invaluable skill-set and wealth of experience to any company in search of capital. His ability to locate, structure and shepherd transactions throughout the process is critical and his connections at virtually every level of Wall Street is of vital importance to any company seeking seed, bridge, mezzanine or ongoing capital up to and beyond the domestic sources serve to compliment the success of any client’s funding endeavors. 

Racz & Company Mentioned here in NY Times Article 1981 

Thomas F. Motter is no scrub promoter IMO... Check out his BIO 

Mr. Motter has worked in the eye care industry for over 30 years, including management 
positions at SmithKline Beckman's eye division over a 15 year period. Mr. Motter founded Paradigm 
Medical and served as Chairman of the Board and Chief Executive Officer of the Company from 1993 
to 2002. As founder of Paradigm Medical, Mr. Motter pioneered the use of Nd-yag laser for cataract 
removal and was at the forefront in the introduction of new surgical procedures utilizing ultrasound and 
laser technologies in all facets of soft tissue management.

SmithKline Beckman was merged with what ultimately became GSK one of the largest pharma companies behind Pfizer 

The Beecham Group plc was a British pharmaceutical company. It was once a constituent of the FTSE 100 Index. Beecham, after having merged with SmithKline Beckman, merged with Glaxo Wellcome to become GlaxoSmithKline (GSK). GSK still uses the Beechams brand name in the UK for its over-the-counter cold and flu relief products.


Randall A. Mackey

Chairman of the Board of Directors, PDMI

Attorney and Counselor at Law at Mackey Price & Mecham



After receiving his two law degrees, Mr. Mackey joined the law firm of Hogan & Hartson in Washington, D.C. where he practiced extensively in the areas of corporate and securities law and administrative law. In 1979, he returned to Utah and joined the Salt Lake City law firm of Fabian & Clendenin. He was a shareholder, Vice President, and a director of that firm prior to joining the predecessor of Mackey Price & Mecham in 1989. While at Fabian & Clendenin, Mr. Mackey’s principal areas of practice included corporate and securities law and banking law. Mr. Mackey also served from 1981 to 1988 as an Adjunct Professor at the University of Utah, teaching courses in Constitutional Law and International Law.

Mr. Mackey has been active in community affairs. He has previously served as Chairman of the Board of Trustees of Salt Lake Community College, a member of the Utah State Board of Education, a director of the Harvard Alumni Association in Cambridge, Massachusetts, a Vice President of the Columbia Law School Association in New York City, and a director of the Salt Lake Education Foundation. Mr. Mackey has also served as a trustee of Ballet West, the Utah Opera Company, and the Gina Bachauer International Piano Foundation and a director of the Utah Arts Counsel.

Mr. Mackey additionally served on the Utah National Steering Committee in 1992 and 1988 of President George Bush’s Campaign Committee, as Chairman of the Higher Education Committee for Governor Jon Huntsman’s Campaign Committee in 2004, a member of Governor Huntsman’s Transition Committee from 2004 to 2005, a member of the Steering Committee of Governor Michael Leavitt’s Campaign Committee in 1992, and a member of the Executive Committee of Governor Leavitt’s Transition Committee from 1992 to 1993.

Mr. Mackey is a member of the Utah State Bar and the District of Columbia Bar and served on the Utah State Bar Securities Advisory Committee.


Extensive experience in corporate and securities matters, including mergers and acquisitions, public offerings and private placements of equity and debt securities, business planning, business sales and divestitures, securities law compliance, shareholder matters, proxy contests, tender offers, joint ventures, limited liability company law, commercial law and insurance law. Has also had significant experience in banking work.


Mackey Price & Mecham is a business law firm based in Salt Lake City, Utah. The firm’s areas of practice include general corporate, corporate finance and securities, litigation and alternative dispute resolution, real estate, banking, estate planning, and aviation law. Mackey Price & Mecham was founded to service the needs of business organizations and enjoys a broad-based business practice.

The firm has two principal objectives: first, to provide mature businesses with the entire spectrum of corporate legal and dispute resolution services at a high level of expertise, and second, to provide emerging businesses with assistance in corporate organization, finance and capital formation, and dispute resolution (as well as assisting with the many other legal and business issues facing emerging businesses). In the past, many top Utah businesses have hired out-of-state legal counsel for representation in complex corporate and securities transactions. Mackey Price & Mecham provides the same quality of legal services on a local basis that are usually found among large out-of-state law firms.

The firm’s attorneys believe that the Rocky Mountain region is an attractive growth area for businesses. Growing businesses need quality representation from experienced legal counsel. Such counsel can facilitate a client’s growth by advising the client on how to locate sources of, and secure capital, assemble a team of professionals and management personnel, and resolve problems and disputes that might inhibit future growth and development. The attorneys at Mackey Price & Mecham are confident that their experience enables them to act as catalysts to the entrepreneurial spirit that prevails in the Rocky Mountain region.

Attorney and Counselor at Law

Fabian & Clendenin

Principal areas of practice included corporate and securities law and banking law.

Attorney and Counselor at Law

Hogan & Hartson

Practiced extensively in the areas of corporate and securities law and administrative law.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#23057   Ok lol! Might be here awhile Risk vs Reward 01/19/17 11:45:47 AM
#23056   Let's see how long it takes to see a WillieWonka 01/19/17 11:36:00 AM
#23055   Willie I agree. I bought MCOA and forgot kittie88 01/18/17 10:25:20 PM
#23054   Hey Kittie, WillieWonka 01/18/17 10:28:05 AM
#23053   Yeah willie but you and me been here kittie88 01/17/17 07:28:14 PM
#23052   Me too, and a hell of a lot WillieWonka 01/17/17 04:13:52 PM
#23051   WW It's been over 2 years. I've been waiting Risk vs Reward 01/17/17 03:34:30 PM
#23050   Hey Risk, WillieWonka 01/17/17 03:26:48 PM
#23049   Had to do it Risk vs Reward 01/17/17 02:27:46 PM
#23048   5th digit is always a reason for belief Risk vs Reward 01/12/17 06:22:14 PM
#23047   Well at least we closed up with that 10k WillieWonka 01/12/17 04:11:25 PM
#23046   I don't mean now, I mean if it WillieWonka 01/12/17 04:04:42 PM
#23045   It's hard and proves oneself an idiot to Risk vs Reward 01/12/17 04:02:39 PM
#23044   Agreed. But even a liberal Socialist wouldn't buy Risk vs Reward 01/12/17 04:01:14 PM
#23043   Hey Risk, WillieWonka 01/12/17 03:57:03 PM
#23042   2's need hit without mercy Risk vs Reward 01/12/17 03:50:45 PM
#23041   Ok thought you saw something different. Risk vs Reward 01/12/17 03:50:12 PM
#23040   And nothing. Just saying that we need to see WillieWonka 01/12/17 03:44:59 PM
#23039   And? Risk vs Reward 01/12/17 03:40:58 PM
#23038   Bid size went down to 500k on no volume. WillieWonka 01/12/17 03:26:16 PM
#23037   Now the bids risen from 3.7 mil to Risk vs Reward 01/12/17 02:22:32 PM
#23036   4th partial fill and still don't have the Risk vs Reward 01/12/17 02:22:01 PM
#23035   Lets see if the .0002's get hit. WillieWonka 01/12/17 01:06:40 PM
#23034   Who knows... Risk vs Reward 01/12/17 12:58:16 PM
#23033   It's not me but CDEL sure came swinging Risk vs Reward 01/12/17 12:57:50 PM
#23032   You think its somebody here, or a newbie? WillieWonka 01/12/17 12:54:24 PM
#23031   You think its somebody here, or a newbie? WillieWonka 01/12/17 12:54:23 PM
#23030   Almost 4 mil on the bid now, haven't Risk vs Reward 01/12/17 11:35:38 AM
#23029   Hey listen Risk, WillieWonka 01/12/17 10:55:15 AM
#23028   79,685 Risk vs Reward 01/12/17 09:54:18 AM
#23027   The bid size is exactly what I haven't Risk vs Reward 01/12/17 09:53:59 AM
#23026   Partial fill city lol Prying the last 1's out?? 3 Risk vs Reward 01/12/17 09:51:32 AM
#23025   Pretty dead on! She has a nice pulse Risk vs Reward 01/12/17 09:02:45 AM
#23024   Hey R vs R, WillieWonka 01/12/17 09:00:07 AM
#23023   I still see no reason to buy more Risk vs Reward 01/11/17 04:35:23 PM
#23022   Fidelity not good for ANY penny stock trader. WillieWonka 01/11/17 02:01:40 PM
#23021   Fidelity ... alert1100 01/11/17 01:53:37 PM
#23020   Who you use? I got Scottrade, no problems there Risk vs Reward 01/11/17 11:03:05 AM
#23019   broker not letting me buy PDMI alert1100 01/11/17 10:49:45 AM
#23018   I'm picking some up Friday myself Risk vs Reward 01/10/17 10:36:16 AM
#23017   looking to buy 3 mil ..waiting for funds alert1100 01/09/17 12:52:31 PM
#23016   300k left boys and girls Risk vs Reward 01/09/17 10:37:00 AM
#23015   Who wants to buy some today?! Get them Risk vs Reward 01/09/17 08:59:58 AM
#23014   I'll say this, if it doesn't happen before Risk vs Reward 01/08/17 10:37:40 AM
#23013   Sitting on free shares so I can afford kittie88 01/08/17 12:27:01 AM
#23012   2017, MAY BE OUR YEAR. CAYO CAYO 01/07/17 10:40:33 PM
#23011   Ok it's 2017! Let the buying begin Risk vs Reward 01/04/17 04:11:14 PM
#23010   lol! True that Risk vs Reward 01/04/17 01:03:03 PM
#23009   At least now we can only go up! WillieWonka 12/30/16 06:01:33 PM
#23008   Think of how many shares 100.00 gets you Risk vs Reward 12/30/16 12:49:36 PM